NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 9, 2009, Pages 3456-3462

  Berger, Michael L ^a   Schweifer, Anna ^b   Rebernik, Patrick ^a   Hammerschmidt, Friedrich ^b  

^a Medical University of Vienna   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

1,2 Diphenylethylamine; 1 (1,2 Diphenylethyl)piperidine; 3H MK 801 binding; NMDA receptor; Spermine

Indexed keywords

1 (1,2 DIPHENYLETHYL)PIPERIDINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENETHYLAMINE DERIVATIVE; PIPERIDINE DERIVATIVE; SPERMINE; STILBYLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOMER; NONHUMAN; RAT; RECEPTOR AFFINITY; STEREOSPECIFICITY;

ANIMALS; BRAIN; DIZOCILPINE MALEATE; KINETICS; MEMBRANES; PHENETHYLAMINES; PIPERIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM;

RATTUS;

EID: 65249173541     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.03.025     Document Type: Article

References (48)

1. Furukawa H., Singh S.K., Mancusso R., and Gouaux E. Nature 438 (2005) 185
2. Kalia L.V., Kalia S.K., and Salter M.W. Lancet Neurol. 7 (2008) 742
3. Wong E.H.F., Knight A.R., and Woodruff G.N. J. Neurochem. 50 (1988) 274
4. Parson C.G., Stöffler A., and Danysz W. Neuropharmacology 53 (2007) 699
5. Rogawski M.A. Trends Pharmacol. Sci. 14 (1993) 325
6. Traynelis S.F., Hartley M., and Heinemann S.F. Science 268 (1995) 873
7. Enomoto R., Ogita K., Han D., and Yoneda Y. Neurosci. Res. 16 (1993) 217
8. Shinohara T., Takeda A., Toda J., and Sano T. Chem. Pharm. Bull. 46 (1998) 430
9. Reddy S.K., Sola L., Moyano A., Pericas M.A., and Riera A. J. Org. Chem. 64 (1999) 3969
10. Goodson L.H., and Christopher H. J. Am. Chem. Soc. 72 (1950) 358
11. Barton D.H.R., and Subramanian R. J. Chem. Soc., Perkin Trans. 1 (1977) 1718
12. Chatgilialoglu C. Acc. Chem. Res. 25 (1992) 188
13. Seco J.M., Quiñoá E., and Riguera R. Chem. Rev. 104 (2004) 17
14. Mitsunobu O. Synthesis (1981) 1
15. Hughes D.L. Org. React. 42 (1992) 335
16. Hughes D.L. Org. Prep. Proced. Int. 28 (1996) 127
17. Neidhöfer J., and Blechert S. Synthesis 18 (2004) 3047
18. Berger M.L. Neurosci. Lett. 296 (2000) 29
19. Riley T.N., and Brier C.G. J. Med. Chem. 15 (1972) 1187
20. Subramaniam S., Donevan S.D., and Rogawski M.A. J. Pharmacol. Exp. Ther. 276 (1996) 161
21. Mealing G.A.R., Lanthorn T.H., Murray C.L., Small D.L., and Morley P. J. Pharmacol. Exp. Ther. 288 (1999) 204
22. Ebert B., Mikkelsen S., Thorkildsen C., and Borgbjerg F.M. Eur. J. Pharmacol. 333 (1997) 99
23. Codd E.E., Shank R.P., Schupsky J.J., and Raffa R.B. J. Pharmacol. Exp. Ther. 274 (1995) 1263
24. Berger M.L., Seifriz I., and Hornykiewicz O. Eur. J. Neurosci. S5 (1992) 2188
25. Ludwig M., Hoesl C.E., Höfner G., and Wanner K.T. Eur. J. Med. Chem. 41 (2006) 1003
26. Sasaki T., and Kanematsu K. J. Med. Chem. 9 (1966) 847
27. Ratti-Moberg E., Groth P., and Aasen A.J. Acta Chem. Scand. 45 (1991) 108
28. Hojahmat M., and Crooks P. AAPS J. 8 (2006) 1533
29. Furukawa H., and Gouaux E. EMBO J. 22 (2003) 2873
30. Yamakura T., Mori H., Masaki H., Shimoji K., and Mishina M. NeuroReport 4 (1993) 687
31. Yamakura T., and Shimoji K. Progr. Neurobiol. 59 (1999) 279
32. Ferrer-Montiel A.V., Sun W., and Montal M. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8021
33. Kashiwagi K., Masuko T., Nguyen C.D., Kuno T., Tanaka I., Igarashi K., and Williams K. Mol. Pharmacol. 61 (2002) 533
34. Rodriguez-Paz J.M., Anantharam V., and Treistman S.N. Neurosci. Lett. 190 (1995) 147
35. Zukin R.S., and Bennet M.V.L. Trends Neurosci. 18 (1995) 306
36. Kashiwagi K., Pahk A.J., Masuko T., Igarashi K., and Williams K. Mol. Pharmacol. 52 (1997) 701
37. Jin L., Miyazaki M., Mizuno S., Takigawa M., Hirose T., Nishimura K., Toida T., Williams K., Kashiwagi K., and Igarashi K. J. Pharmacol. Exp. Ther. 327 (2008) 68
38. Berger M.L. Eur. J. Pharmaceut. Sci. 2 (1994) P127
39. Johnson J.W., and Kotermanski S.E. Curr. Opin. Pharmacol. 6 (2006) 61
40. Moe S.T., Shimizu S.M., Smith D.L., Van Wagenen B.C., DelMar E.G., Balandrin M.F., Chien Y., Raszkiewicz J.L., Artman L.D., Muller A.L., Lobkovsky E., and Clardy J. Bioorg. Med. Chem. Lett. 9 (1999) 1915
41. Raines D.E., Gioia F., Claycomb R.J., and Stevens R.J. J. Pharmacol. Exp. Ther. 311 (2004) 14
42. Mikenda W. Vib. Spectrosc. 3 (1992) 327
43. Smith H.E., and Willis T.C. J. Am. Chem. Soc. 93 (1971) 2282
44. Parker D., and Taylor R.J. Tetrahedron 43 (1987) 5451
45. Kasé Y., Yuizono T., and Muto M. J. Med. Chem. 6 (1963) 118
46. La Manna A., Ghislandi V., Scopes P.M., and Swan R.J. Il Farmaco-Ed. Sc. 20 (1965) 842
47. Yoneda Y., and Ogita K. Brain Res. 499 (1989) 305
48. Cheng Y.-C., and Prusoff W.H. Biochem. Pharmacol. 22 (1973) 3099